LOINC Code Information

Test Classification

This test was developed and its performance characteristics
determined by Mayo Clinic in a manner consistent with CLIA
requirements. This test has not been cleared or approved by the
U.S. Food and Drug Administration.

Testing Algorithm

This is a second-order test that should be used when the test
for the JAK2M / JAK2
V617F Mutation Detection, Bone Marrow test is negative.

See Myeloproliferative Neoplasm: A Diagnostic Approach to Bone
Marrow Evaluation in Special Instructions.